2015 American Transplant Congress » Concurrent Session: Kidney: Desensitization

Date: Monday, May 4, 2015

Time: 2:15pm-3:45pm

Location: Terrace I-III

Session Type: Concurrent Session

Meeting: 2015 American Transplant Congress

2:15pm-2:27pm: Extended Analysis of Tocilizumab (anti-IL-6R) + Intravenous Immunoglobulin (IVIG) as Desensitization (DES) Agents for Reduction of Donor Specific Antibodies (DSA) in Patients Resistant to DES With IVIG + Rituximab

A. Vo, J. Choi, I. Kim, J. Kahwaji, A. Peng, R. Villicana, S. Jordan.

2:27pm-2:39pm: Quantifying the Survival Benefit of HLA-Incompatible Kidney Transplantation: A Multi-Center Study

B. Orandi, X. Luo, A. Massie, J. Garonzik-Wang, B. Lonze, R. Ahmed, K. Van Arendonk, R. Montgomery, D. Segev.

2:39pm-2:51pm: Long-Term Analysis of a Placebo-Controlled Trial of C1-INH for Prevention of Antibody-Mediated Rejection

A. Vo, J. Choi, J. Kahwaji, D. Puliyanda, A. Peng, R. Villicana, S. Jordan.

2:51pm-3:03pm: Long-Term Excellent Results of ABO-Incompatible Kidney Transplantations at Multicenter Japanese Case Series

K. Tanabe,^１ H. Ishida,^１ K. Masutani,² Y. Okabe,³ M. Okumi,¹ H. Kitada,² T. Shimizu,⁴ H. Shirakawa.⁵

3:03pm-3:15pm: Etiology, Incidence and Outcomes of the Highly Sensitized Kidney Transplant Patient

R. Redfield, T. Zens, J. Scalea, M. Rizzari, D. Mandelbrot, D. Kaufman, A. Djamali.

3:15pm-3:27pm: The Impact of a Desensitization Protocol Using Plasmapheresis and Intravenous Immunoglobulin On Graft Outcome in Kidney Recipients With Donor Specific Anti-HLA Antibodies

J. Junqueira, T. Leite, A. Junqueira, R. Esmeraldo.

3:27pm-3:39pm: Favorable Results of ABO Incompatible Renal Transplantation Without B Cell Targeted Therapy: Advantages and Disadvantages of Rituximab Pretreatment

M. Okada,¹ K. Futamura,¹ K. Itou,¹ T. Yamamoto,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ S. Narumi,¹ Y. Watarai,¹ A. Katayama,² K. Uchida,³ T. Kobayashi.⁴

« View all sessions from the 2015 American Transplant Congress